Johnson & Johnson to get $1bn for potential vaccine 

US in vaccine deal with Johnson and Johnson as it stocks up on treatments in an attempt to tame the coronavirus pandemic

J&J is studying both one and two-dose regimens of its Covid-19 vaccine.

The US government will pay Johnson & Johnson over $1bn (€850m) for 100m doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.

The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456m the US government promised to J&J for vaccine development in March.